Heart transplantation in a patient with chloroquine-induced cardiomyopathy.
We present the first report of a patient who underwent heart transplantation (HT) after endomyocardial biopsy (EMB) and revealed chloroquine-induced cardiomyopathy (CIC). This patient, who was treated with chloroquine for 6 years, developed a restrictive cardiomyopathy that progressed to congestive heart failure (CHF) resistant to medical management.
Freihage
Jeffrey H
JH
Division of Cardiology, Department of Medicine, Loyola University Health System, Maywood, Illinois 60153, USA. jfreih@lumc.edu
Patel
Nehu C
NC
Jacobs
William R
WR
Picken
Maria
M
Fresco
Raoul
R
Malinowska
Krystyna
K
Pisani
Barbara A
BA
Mendez
Jose C
JC
Lichtenberg
Robert C
RC
Foy
Bryan K
BK
Bakhos
Mamdouh
M
Mullen
G Martin
GM
D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002313:Cardiomyopathy, Restrictive / Q000139:chemically induced* / Q000601:surgery*; D002738:Chloroquine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006333:Heart Failure / Q000139:chemically induced / Q000601:surgery; D016027:Heart Transplantation; D006801:Humans; D008875:Middle Aged; D013997:Time Factors
D018501:Antirheumatic Agents; D002738:Chloroquine